Literature DB >> 19506091

The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.

Udo Jeschke1, Hermann Walzel, Ioannis Mylonas, Panos Papadopoulos, Naim Shabani, Christina Kuhn, Sandra Schulze, Klaus Friese, Uwe Karsten, David Anz, Markus S Kupka.   

Abstract

Mucin 1 (MUC1) is a glycoprotein in human endometrium and is abundant at the luminal epithelial surface in the receptive phase. It has a highly glycosylated ecto-domain that contains keratan sulfate chains, that disappears at the time of implantation. In addition, the glycoforms on MUC1 differ in fertile and infertile women. Therefore the aims of this study were investigations on glycosylation of MUC1 with the Thomsen-Friedenreich (TF) epitope on normal human endometrium throughout the menstrual cycle and binding of galectin-1 on the TF epitope in the endometrium and the expression of galectin-1 on the human oocyte. Human endometrial tissue was obtained from 54 premenopausal patients and was immunohistochemically analyzed with monoclonal antibodies against MUC1, TF epitope, galectin-1, and biotinylated galectin-1. In addition, human oocytes were analyzed for TF, galectin-1 expression, and galectin-1 binding. We identified a significant upregulation of MUC1 and TF epitope and, in addition, galectin-1 binding in glandular epithelium and epithelial apical surface tissue from proliferative to secretory phase. With double staining experiments, we identified a coexpression of TF and MUC1 in the early secretory phase and galectin-1 binding to TF during the same period of time. In addition we identified TF epitope and galectin-1 expression plus binding on the human oocyte and irregularly fertilized oocytes. Upregulation of TF epitope on the glandular epithelium and epithelial apical surface tissue in the secretory phase and binding of galectin-1 at the same time show the possibility of galectin-1-mediated trophectoderm binding to the endometrium within the window of implantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506091      PMCID: PMC2728131          DOI: 10.1369/jhc.2009.952085

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  57 in total

Review 1.  MUC1, endometrium and embryo implantation.

Authors:  J D Aplin; N A Hey
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

2.  Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue.

Authors:  B Woynarowska; C J Dimitroff; M Sharma; K L Matta; R J Bernacki
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  An examination of the variation in timed endometrial biopsies.

Authors:  P Dockery; T C Li; A W Rogers; I D Cooke; E A Lenton; M A Warren
Journal:  Hum Reprod       Date:  1988-08       Impact factor: 6.918

Review 4.  Trophinin, tastin, and bystin: a complex mediating unique attachment between trophoblastic and endometrial epithelial cells at their respective apical cell membranes.

Authors:  M N Fukuda; S Nozawa
Journal:  Semin Reprod Endocrinol       Date:  1999

5.  Menstrual-cycle-dependent expression of keratan sulphate in human endometrium.

Authors:  M E Hoadley; M W Seif; J D Aplin
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  Muc-1, integrin, and osteopontin expression during the implantation cascade in sheep.

Authors:  G A Johnson; F W Bazer; L A Jaeger; H Ka; J E Garlow; C Pfarrer; T E Spencer; R C Burghardt
Journal:  Biol Reprod       Date:  2001-09       Impact factor: 4.285

7.  Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.

Authors:  Udo Jeschke; Uwe Karsten; Irmi Wiest; Sandra Schulze; Christina Kuhn; Klaus Friese; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2006-04-11       Impact factor: 4.304

8.  Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro.

Authors:  Vanesa G Martinez; Eliana H Pellizzari; Emilce S Díaz; Selva B Cigorraga; Livia Lustig; Berta Denduchis; Carlota Wolfenstein-Todel; M Mercedes Iglesias
Journal:  Glycobiology       Date:  2003-11-24       Impact factor: 4.313

9.  Human placenta beta-galactoside-binding lectin. Purification and some properties.

Authors:  J Hirabayashi; K Kasai
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

10.  Expression of N-linked sialyl Le(x) determinants and O-glycans in the carbohydrate moiety of human amniotic fluid transferrin during pregnancy.

Authors:  J J van Rooijen; U Jeschke; J P Kamerling; J F Vliegenthart
Journal:  Glycobiology       Date:  1998-11       Impact factor: 4.313

View more
  13 in total

Review 1.  Interaction of extravillous trophoblast galectin-1 and mucin(s)-Is there a functional relevance?

Authors:  Žanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Toshihiko Kadoya; Ljiljana Radojčić; Ljiljana Vićovac
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

2.  Galectin-1 binds mucin in human trophoblast.

Authors:  Zanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Miloš Petronijević; Svetlana Vrzić-Petronijević; Snežana Golubović; Ljiljana Vićovac
Journal:  Histochem Cell Biol       Date:  2014-05-23       Impact factor: 4.304

3.  Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.

Authors:  Hironori Kumagai; Wellington Pham; Makoto Kataoka; Ken-Ichiro Hiwatari; James McBride; Kevin J Wilson; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Eric H Liu; John C Gore; Shinji Sakuma
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

4.  TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.

Authors:  Forrest G FitzGerald; Maria C Rodriguez Benavente; Camelia Garcia; Yaima Rivero; YashoNandini Singh; Hongjie Wang; Gregg B Fields; Maré Cudic
Journal:  Glycoconj J       Date:  2020-10-01       Impact factor: 2.916

5.  Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.

Authors:  Stefan Hutter; Diana M Morales-Prieto; Ulrich Andergassen; Lisa Tschakert; Christina Kuhn; Simone Hofmann; Udo R Markert; Udo Jeschke
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

6.  Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

Authors:  Miriam Lenhard; Alexandra Tsvilina; Lan Schumacher; Markus Kupka; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

Review 7.  The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1.

Authors:  Jonathan M Cousin; Mary J Cloninger
Journal:  Int J Mol Sci       Date:  2016-09-16       Impact factor: 5.923

8.  Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells.

Authors:  Shaqiu Zhang; Ni Zeng; Nour Alowayed; Yogesh Singh; Anchun Cheng; Florian Lang; Madhuri S Salker
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

9.  Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Authors:  Miriam Lenhard; Lennerová Tereza; Sabine Heublein; Nina Ditsch; Isabelle Himsl; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-11-24       Impact factor: 4.430

10.  Identification of Loci and Pathways Associated with Heifer Conception Rate in U.S. Holsteins.

Authors:  Justine M Galliou; Jennifer N Kiser; Kayleen F Oliver; Christopher M Seabury; Joao G N Moraes; Gregory W Burns; Thomas E Spencer; Joseph Dalton; Holly L Neibergs
Journal:  Genes (Basel)       Date:  2020-07-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.